Development and validation of a production process of platelet lysate for autologous use

Platelets

Volumn 22, Issue 3, 2011, Pages 204-209

  Plöderl, Karin ^a   Strasser, Cornelia ^a   Hennerbichler, Simone ^a   Peterbauer Scherb, Anja ^a   Gabriel, Christian ^a  

^a Red Cross Transfusion Service of Upper Austria   (Austria)

Author keywords

cosmetic surgery; Platelet lysate; platelet rich plasma; process development; validation

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICLE; ASEPSIS; BLOOD DONOR; CELL LYSATE; CELL SEPARATION; CENTRIFUGATION; ERYTHROCYTE COUNT; FREEZE THAWING; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; NORMAL HUMAN; PLATELET LYSATE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; BLOOD TRANSFUSION, AUTOLOGOUS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PLATELET COUNT;

EID: 79954454998     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.531304     Document Type: Article

References (27)

1. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous Platelets as a Source of Proteins for Healing and Tissue Regeneration. Thromb Haemost 2004;91:4-15. (Pubitemid 38111215)
2. Bayes - Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res 2000;86:125-130.
3. Böttcher RT, Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev. 2005;26:63-77. (Pubitemid 40209387)
4. Gospodarowicz D. Fibroblast growth factor - chemical structure and biologic function. Clin Orthop Relat Res 1990;257:231-248. (Pubitemid 20246747)
5. Wahl SM. Transforming growth factor : The good, the bad, and the ugly. J Exp Med 1994;180:1587-1590.
6. Walsh G. Pharmaceutical biotechnology - concepts and applications (1st edition). Chichester, UK: John Wiley & Sons Ltd, 2007.
7. Everts PA, Jakimowicz JJ, van Beek M, Schönberger JP, Devilee RJ, Overdevest EP, Knape JT, van Zundert A. Reviewing the structural features of autologous plateletleukocyte gel and suggestions for use in surgery. Eur Surg Res 2007;39:199-207. (Pubitemid 47000366)
8. Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, et al. Thrombocidins, microbial proteins from human blood platelets, are c-terminal deletion products of CXC chemokines. J Biol Chem 2000;275:20374-20381. (Pubitemid 30457613)
9. Welsh WJ. Autologous platelet gel - clinical function and usage in plastic surgery. Cosmet Dermatol 2000;13:13-19.
10. Lieberman JR, Daluiski A, Einhorn TA. Current concepts review: The role of growth factors in the repair of bone. J Bone Joint Surg Am 2002;84:1032-1044.
11. Chajchir A, Fabrizio D, Chajchir G, Celi E. Growth factors in plastic surgery. Aesthetic Plast Surg 2005;29:295-299. (Pubitemid 41205610)
12. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002;18:27-33. (Pubitemid 34133954)
13. Man D, Plosker H, Winland-Brown J. The use of autologous platelet-rich plasma ( platelet gel) and autologus platelet poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001;107:229-237.
14. Hom DB, Thatcher G, Tibesar R. Growth factor therapy to improve soft tissue healing. Facial Plast Surg 2002;18: 41-52. (Pubitemid 34131102)
15. Por YC, Shi L, Samuel M, Song C, Yeow VK. Use of tissue sealants in face-lifts: A metaanalysis. Aesthetic Plast Surg 2009;33:336-339.
16. Powell DM, Chang E, Farrior EH. Recovery from deepplane rhytidectomy following unilateral wound treatment with autologous platelet gel. Arch Facial Plast Surg 2001;3: 245-250.
17. Commission directive 2003/94/EC laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use, 2003. Official Journal of the European Union, European Commission, Brussels
18. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Annex 1 Manufacture of Sterile Medicinal Products.
19. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 13th ed. Strasbourg Cedex, France: Council of Europe Publishing; 2007.
20. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992;18:445-456.
21. Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, Schettert IT, Krieger JE. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 2009;49:2680-2685.
22. Woodell-May JE, Ridderman DN, Swift MJ, Higgins J. Producing accurate platelet counts for platelet rich plasma: Validation of a hematology analyzer and preparation techniques for counting. J Craniofac Surg 2005;16:749-756. (Pubitemid 41428918)
23. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002;30: 97-102. (Pubitemid 34846492)
24. Borzini P, Mazzucco L, Panizza R, Rivara G. Regarding ''Randomized trial and local biological effect of autologous platelets used in adjuvant therapy for chronic venous leg ulcers.'' J Vasc Surg 2004;39:1146-1147. (Pubitemid 38581656)
25. Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F, Dubertret L, Dosquet C. Randomized trial and local biological effect of autologous platelets used in adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 2003;38:1342-1348. (Pubitemid 37517667)
26. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999;83: 390-395. (Pubitemid 29161176)
27. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, Kuwana M, Tsubota K, Ikeda Y, Oguchi Y. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003;31:579-583. (Pubitemid 36546837)